Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin

Biochimie

Volumn 93, Issue 3, 2011, Pages 426-433

  Krust, Bernard ^a   El Khoury, Diala ^a   Soundaramourty, Calaiselvy ^a   Nondier, Isabelle ^a   Hovanessian, Ara G ^a  

^a CNRS   (France)

Author keywords

Antagonist peptide; Contact inhibition; G401 cells; Surface nucleolin; Tumorigenicity

Indexed keywords

AGAR; CELL SURFACE PROTEIN; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HB 19 PSEUDOPEPTIDE; HERMES ANTIGEN; MIDKINE; MYC PROTEIN; NUCLEOLIN; PROTEIN BAX; PROTEIN BCL 2; PSEUDOPEPTIDE; THROMBOSPONDIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANCHORAGE INDEPENDENT GROWTH; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE C MYC; PHENOTYPE; PROTEIN EXPRESSION; RHABDOID TUMOR; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MATRIX METALLOPROTEINASE 2; MICE; PEPTIDOMIMETICS; PHOSPHOPROTEINS; PROTEIN BINDING; RHABDOID TUMOR; RNA, MESSENGER; RNA-BINDING PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WT1 PROTEINS;

MUS; MUS MUSCULUS;

EID: 79951509704     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2010.10.015     Document Type: Article

References (78)

1. M. Srivastava, and H.B. Pollard Molecular dissection of nucleolin's role in growth and cell proliferation: new insights FASEB J. 13 1999 1911 1922 (Pubitemid 29517621)
2. H. Ginisty, H. Sicard, B. Roger, and P. Bouvet Structure and functions of nucleolin J. Cell Sci. 112 1999 761 772 (Pubitemid 29179310)
3. S. Storck, M. Shukla, S. Dimitrov, and P. Bouvet Functions of the histone chaperone nucleolin in diseases Subcell. Biochem. 41 2007
4. M. Fahling, A. Steege, A. Perlewitz, B. Nafz, R. Mrowka, P.B. Persson, and B.J. Thiele Role of nucleolin in posttranscriptional control of MMP-9 expression Biochim. Biophys. Acta 1731 2005 32 40 (Pubitemid 41463598)
5. Y. Otake, S. Soundararajan, T.K. Sengupta, E.A. Kio, J.C. Smith, M. Pineda-Roman, R.K. Stuart, E.K. Spicer, and D.J. Fernandes Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA Blood 109 2007 3069 3075 (Pubitemid 46482108)
6. A.G. Hovanessian, F. Puvion-Dutilleul, S. Nisole, J. Svab, E. Perret, J.S. Deng, and B. Krust The cell-surface-expressed nucleolin is associated with the actin cytoskeleton Exp. Cell Res. 261 2000 312 328 (Pubitemid 32010228)
7. A.G. Hovanessian Midkine is a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin Cell Res. 16 2006 174 181 (Pubitemid 43247974)
8. + cells J. Biol. Chem. 273 1998 21988 21997 (Pubitemid 28405379)
9. S. Nisole, E.A. Said, C. Mische, M.C. Prevost, B. Krust, P. Bouvet, A. Bianco, J.P. Briand, and A.G. Hovanessian The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells, J. Biol. Chem. 277 2002 20877 20886 (Pubitemid 34967396)
10. S. Nisole, B. Krust, and A.G. Hovanessian Anchorage of HIV on permissive cells leads to co-aggregation of viral particles with surface nucleolin at membrane raft microdomains Exp. Cell Res. 276 2002 155 173 (Pubitemid 34969310)
11. J.F. Sinclair, and A.D. O'Brien Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7 J. Biol. Chem. 277 2002 2876 2885 (Pubitemid 34953321)
12. M. Barel, A.G. Hovanessian, K. Meibom, J.P. Briand, M. Dupuis, and A. Charbit A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu, BMC Microbiol. 8 2008 145 10.1186/1471-2180-1188-1145
13. A.G. Hovanessian, C. Soundaramourty, D. El Khoury, I. Nondier, J. Svab, B. Krust, Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization, submitted for publication.
14. M.E. Losfeld, D. El Khoury, P. Mariot, M. Carpentier, B. Krust, J.P. Briand, J. Mazurier, A.G. Hovanessian, and D. Legrand The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells Exp. Cell Res. 315 2009 357 369
15. S. Aldi, C. Della Giovampaola, R. Focarelli, A. Armini, M. Ziche, F. Finetti, and F. Rosati A fucose-containing O-glycoepitope on bovine and human nucleolin Glycobiology 19 2009 337 343
16. S. Nisole, B. Krust, C. Callebaut, G. Guichard, S. Muller, J.P. Briand, and A.G. Hovanessian The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface expressed nucleolin independent of heparan sulfate proteoglycans, J. Biol. Chem. 274 1999 27875 27884
17. A.E. Said, B. Krust, S. Nisole, J.P. Briand, and A.G. Hovanessian The anti-HIV cytokine midkine binds the cell-surface-expressed nucleolin as a low affinity receptor J. Biol. Chem. 277 2002 37492 37502
18. D. Legrand, K. Vigie, E.A. Said, E. Elass, M. Masson, M.C. Slomianny, M. Carpentier, J.P. Briand, J. Mazurier, and A.G. Hovanessian Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells Eur. J. Biochem. 271 2004 303 317 (Pubitemid 38130458)
19. E.A. Said, J. Courty, J. Svab, J. Delbé, B. Krust, and A.G. Hovanessian Pleiotrophin inhibits HIV infection by binding the cell surface expressed nucleolin FEBS J. 272 2005 4646 4659 (Pubitemid 41366988)
20. V. Stepanova, T. Lebedeva, A. Kuo, S. Yarovoi, S. Tkachuk, S. Zaitsev, K. Bdeir, I. Dumler, M.S. Marks, Y. Parfyonova, V.A. Tkachuk, A.A. Higazi, and D.B. Cines Nuclear translocation of urokinase-type plasminogen activator Blood 112 2008 100 110
21. Y. Shibata, T. Muramatsu, M. Hirai, M. Inui, T. Kimura, H. Saito, L.M. McCormack, G. Bu, and K. Kadomatsu Nuclear targeting by the growth factor midkine Mol. Cell. Biol. 22 2002 6788 6796
22. E. Grinstein, and P. Wernet Cellular signaling in normal and cancerous stem cells Cell Signal. 19 2007 2428 2433 (Pubitemid 47531926)
23. D.E. Alete, M.E. Weeks, A.G. Hovanessian, M. Hawadle, and A.W. Stoker Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma FEBS J. 273 2006 4668 4681 (Pubitemid 44506908)
24. A. Di Segni, K. Farin, and R. Pinkas-Kramarski Identification of nucleolin as new ErbB receptors- interacting protein PLoS ONE 3 6 2008 e2310
25. E.M. Reyes-Reyes, and S.K. Akiyama Cell-surface nucleolin is a signal transducing P-selectin binding protein for human colon carcinoma cells Exp. Cell Res. 314 2008 2212 2223
26. K.L. Inder, C. Lau, D. Loo, N. Chaudhary, A. Goodall, S. Martin, A. Jones, D. van der Hoeven, R.G. Parton, M.M. Hill, and J.F. Hancock Nucleophosmin and nucleolin regulate K-Ras plasma membrane interactions and MAPK signal transduction J. Biol. Chem. 284 2009 28410 28419
27. H.K. Kleinman, B.S. Weeks, F.B. Cannon, T.M. Sweeney, G.C. Sephel, B. Clement, M. Zain, M.O.J. Olson, M. Jucker, and B.A. Burrous Identification of a 110-kDa nonintegrin cell surface laminin-binding protein which recognizes an A chain neurite-promoting peptide Arch. Biochem. Biophys. 290 1991 320 325
28. S. Larrucea, C. Gonzalez-Rubio, R. Cambronero, B. Ballou, P. Bonay, E. Lopez-Granados, P. Bouver, M. Fontan, M. Fresno, and M. Lopez-Trascasa Cellular adhesion mediated by factor J, a complement inhibitor. Evidence for nucleolin involvement J. Biol. Chem. 273 1998 31718 31725 (Pubitemid 29177101)
29. G. Harms, R. Kraft, G. Grelle, B. Volz, J. Dernedde, and R. Tauber Identification of nucleolin as a new L-selectin ligand Biochem. J. 360 2001 531 538 (Pubitemid 34020257)
30. S. Christian, J. Pilch, M.E. Akerman, K. Porkka, P. Laakkonen, and E. Ruoslahti Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels J. Cell Biol. 163 2003 871 878 (Pubitemid 37517893)
31. K. Kadomatsu, and T. Muramatsu Midkine and pleiotrophin in neural development and cancer Cancer Lett. 204 2004 127 143 (Pubitemid 38167717)
32. A. Tate, S. Isotani, M.J. Bradley, R.A. Sikes, R. Davis, L.W. Chung, and M. Edlund Met-independent hepatocyte growth factor-mediated regulation of cell adhesion in human prostate cancer cells BMC Cancer 6 2006 197 212
33. N. Turck, O. Lefebvre, I. Gross, P. Gendry, M. Kedinger, P. Simon-Assmann, and J.F. Launay Effect of laminin-1 on intestinal cell differentiation involves inhibition of nuclear nucleolin J. Cell Physiol. 206 2006 545 555 (Pubitemid 43062826)
34. Y. Huang, H. Shi, Z. Hau, X. Song, S. Yuan, and Y. Luo The angiogenesis function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin Blood 107 2006 3564 3571
35. H. Shi, Y. Huang, H. Zhou, X. Song, S. Yuan, Y. Fu, and Y. Luo Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin Blood 110 2007 2899 2906 (Pubitemid 350006943)
36. P. Perez-Pinera, J.R. Berenson, and T.F. Deuel Pleiotrophin, a multifunctional angiogenic factor: mechanisms and pathways in normal and pathological angiogenesis Curr. Opin. Hematol. 15 2008 210 214 (Pubitemid 351507573)
37. D. Destouches, D. El Khoury, Y. Hamma-Kourbali, B. Krust, P. Albanese, P. Katsoris, G. Guichard, J.P. Briand, J. Courty, and A.G. Hovanessian Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin PLoS ONE 3 6 2008 e2518
38. D. El Khoury, D. Destouches, R. Lengagne, B. Krust, Y. Hamma-Kourbali, M. Garcette, S. Niro, M. Kato, J.P. Briand, J. Courty, A.G. Hovanessian, and A. Prevost-Blondel Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET Transgenic mice BMC Cancer 10 2010 325 337
39. X. Xu, F. Hamhouyia, S.D. Thomas, T.J. Burke, A.C. Girvan, W.G. McGregor, J.O. Trent, D.M. Miller, and P.J. Bates Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides J. Biol. Chem. 276 2001 43221 43230
40. P.J. Bates, D.A. Laber, D.M. Miller, S.D. Thomas, and J.O. Trent Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer Exp. Mol. Pathol. 86 2009 151 164
41. S. Soundararajan, L. Wang, V. Sridharan, W. Chen, N. Courtenay-Luck, D. Jones, E.K. Spicer, and D.J. Fernandes Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells Mol. Pharmacol. 76 2009 984 991
42. A.C. Girvan, Y. Teng, L.K. Casson, S.D. Thomas, S. Jüliger, M.W. Ball, J.B. Klein, W.M. Pierce Jr., S.S. Barve, and P.J. Bates AGR0100 inhibits activation of nuclear factor-kappaB (NF-kappaB) by forming a complex with NF-kappaB essential modulator (NEMO) and nucleolin Mol. Cancer Ther. 5 2006 1790 1799 (Pubitemid 44323247)
43. Y. Teng, A.C. Girvan, L.K. Casson, W.M. Pierce Jr., M. Qian, S.D. Thomas, and P.J. Bates AS1411 alters localization of a complex containing protein arginine methyltransferase 5 and nucleolin Cancer Res. 67 2007 10491 10500 (Pubitemid 350070825)
44. S. Soundararajan, W. Chen, E.K. Spicer, N. Courtenay-Luck, and D.J. Fernandes The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells, Cancer Res. 68 2008 2358 2365 (Pubitemid 351521810)
45. C.W. Roberts, and J.A. Biegel The role of SMARCB1/INI1 in development of rhabdoid tumor, Cancer Biol. Ther. 8 2009 412 416
46. M.E. Smith, V. Cimica, S. Chinni, K. Challagulla, S. Mani, and G.V. Kalpana Rhabdoid tumor growth is inhibited by flavopiridol Clin. Cancer Res. 14 2008 523 532 (Pubitemid 351226122)
47. A.J. Garvin, G.G. Re, B.I. Tarnowski, D.J. Hazen-Martin, and D.A. Sens The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney Am. J. Pathol. 142 1993 375 380 (Pubitemid 23057449)
48. C. Callebaut, E. Jacotot, G. Guichard, B. Krust, M.A. Rey-Cuille, D. Cointe, N. Benkirane, J. Blanco, S. Muller, J.P. Briand, and A.G. Hovanessian Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death Virology 218 1996 181 192 (Pubitemid 26133097)
49. S.Y. Cheranov, M. Karpurapu, D. Wang, B. Zhang, R.C. Venema, G.N. Rao, An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis, Blood 111 (2008) 558-591.
50. T. Vincent, and N. Mechti IL-6 regulates CD44 cell surface expression on human myeloma cells Leukemia 18 2004 967 975 (Pubitemid 38714622)
51. S.A. Lee, S.Y. Lee, I.H. Cho, M.A. Oh, E.S. Kang, Y.B. Kim, W.D. Seo, S. Choi, J.O. Nam, M. Tamamori-Adachi, S. Kitajima, S.K. Ye, S. Kim, Y.J. Hwang, I.S. Kim, K.H. Park, and J.W. Lee Tetraspanin TM4SF5 mediates loss of contact inhibition through epithelial-mesenchymal transition in human hepatocarcinoma J. Clin. Invest. 118 2008 1354 1366 (Pubitemid 351500429)
52. V. Scharnhorst, A.J. van der Eb, and A.G. Jochemsen WT1 proteins: functions in growth and differentiation Gene 273 2001 141 161 (Pubitemid 32786908)
53. V. González, K. Guo, L. Hurley, and D. Sun Identification and characterization of nucleolin as a c-myc G-quadruplex-binding protein J. Biol. Chem. 284 2009 23622 23635
54. D. Ishimaru, L. Zuraw, S. Ramalingam, T.K. Sengupta, S. Bandyopadhyay, A. Reuben, D.J. Fernandes, E.K. Spicer, Mechanism of regulation of Bcl-2 mRNA by nucleolin and A+U rich element binding factor 1 (AUF1). J. Biol. Chem., in press.
55. B. Zhang, H. Wang, B. Jiang, P. Liang, M. Liu, G. Deng, and X. Xiao Nucleolin/C23 is a negative regulator of hydrogen peroxide-induced apoptosis in HUVECs Cell Stress Chaperones 2009 10.1007/s12192-009-0138-5
56. L. Lindenboim, E. Blacher, C. Borner, and R. Stein Regulation of stress-induced nuclear protein redistribution: a new function of Bax and Bak uncoupled from Bcl-xL Cell Death. Differ. 17 2010 346 3359
57. A.M. Byrne, D.J. Bouchier-Hayes, and J.H.J.H. Harmey Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF) JCMM 9 2005 777 794 (Pubitemid 43116546)
58. S. Kazerounian, K.O. Yee, and J. Lawler Thrombospondins in cancer Cell. Mol. Life Sci. 65 2008 700 712
59. K. Kessenbrock, V. Plaks, and Z. Werb Matrix metalloproteinases: regulators of the tumor microenvironment Cell 141 2010 52 67
60. W. Cruz-Munoz, and R. Khokha The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis, Crit. Rev. Clin.Lab. Sci. 45 2008 291 338 (Pubitemid 351883130)
61. L.Y.W. Bourguignon Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression Semin. Cancer Biol. 18 2008 251 259
62. L.Y.W. Bourguignon, D. Zhu, and H. Zhu CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression Front. Biosci. 3 1998 d637 649
63. T. Jomgeow, Y. Oji, N. Tsuji, Y. Ikeda, K. Ito, A. Tsuda, T. Nakazawa, N. Tatsumi, N. Sakaguchi, S. Takashima, T. Shirakata, S. Nishida, N. Hosen, M. Kawakami, A. Tsuboi, Y. Oka, K. Itoh, and H. Sugiyama Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro Cancer Sci. 97 2006 259 570
64. E.I. Deryugina, and J.P. Quigley Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev. 25 2006 9 34 (Pubitemid 43723979)
65. H. Werner, Z. Shen-Orr, F.J. Rauscher, J.F. Morris, C.T. Roberts, and D. LeRoith Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression Mol. Cell. Biol. 15 1995 3516 3522
66. L. Yang, Y. Han, F. Suarez Saiz, and M.D. Minden A tumor suppressor and oncogene: the WT1 story Leukemia 21 2007 868 876 (Pubitemid 46672061)
67. S. Ariyaratana, and D.M. Loeb The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis Expert Rev. Mol. Med. 9 2007 1 17 (Pubitemid 46965072)
68. Y. Oka, A. Tsuboi, F. Fujiki, Z. Li, H. Nakajima, N. Hosen, T. Shirakata, S. Nishida, Y. Oji, I. Kawase, and H. Sugiyama WT1 peptide vaccine as a paradigm for "cancer antigen-derived peptide"-based immunotherapy for malignancies: successful induction of anti-cancer effect by vaccination with a single kind of WT1 peptide Anticancer Agents Med. Chem. 9 2009 787 797
69. H. Ponta, L. Sherman, and P.A. Herrlich CD44: from adhesion moleculles to signaling regulators Nat. Rev. Mol. Cell Biol. 4 2003 33 45 (Pubitemid 36077255)
70. N. Iida, and L.Y.W. Bourguignon New CD44 splice variants associated with human breast cancers J. Cell Physiol. 162 1995 127 133
71. N. Iida, and L.Y.W. Bourguignon Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis J. Cell Physiol. 171 1997 152 160 (Pubitemid 27205056)
72. Y. Kitahori, M. Cho, N. Konishi, M. Ohshima, E. Matsui, T. Ohnishi, S. Imai, and Y. Hiasa Overexpression of CD44 variant transcripts in rat transplantable thyroid carcinoma lines demonstrating lung metastasis Int. J. Cancer 13 1998 505 511 (Pubitemid 28372673)
73. L.Y.W. Bourguignon, H. Zhu, L. Shao, D. Zhu, and Y.W. Chen Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells Cell Motil. Cytoskeleton 43 1999 269 287 (Pubitemid 29368201)
74. E.A. Ratovitski, P.T. Kotzbauer, J. Milbrandt, C.J. Lowenstein, and C.R. Burrow Midkine induces tumor cell proliferation and binds to a high affinity signaling receptor associated with JAK tyrosine kinases J. Biol. Chem. 263 1998 3654 3660 (Pubitemid 28109792)
75. H. Muramatsu, H. Shirahama, S. Yonezawa, H. Maruta, and T. Muramatsu Midkine, a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution Dev. Biol. 159 1993 392 402 (Pubitemid 23334066)
76. K. Kadomatsu, M. Hagihara, S. Akhter, Q. Fan, H. Muramatsu, and T. Muramatsu Midkine induces the transformation of NIH3T3 cells Brit. J. Cancer 75 1997 354 359 (Pubitemid 27051049)
77. Y. Takei, K. Kadomatsu, K. Yuasa, W. Sato, and T. Muramatsu Morpholino antisense oligomer targeting human midkine: its application for cancer therapy Int. J. Cancer 114 2005 490-197
78. S. Chen, G. Bu, Y. Takei, K. Sakamoto, S. Ikematsu, T. Muramatsu, and K. Kadomatsu Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells J. Cell Sci. 120 2007 4009-1015